Invitrogen this week announced the availability of the Stempro human adipose- derived stem cell kit.
The kit consists of adipose-derived stem cells from human lipoaspirate tissue obtained under license from Cytori Therapeutics, which are passaged once before they are cryopreserved from primary cultures.
The kit also includes MesenPRO RS medium, a reduced serum (2 percent) medium optimized for the expansion of human mesenchymal stem cells.
Compared with bone marrow-derived mesenchymal stem cells, ADSCs have very similar phenotypic and functional characteristics and have an equal potential to differentiate into cells and tissues of mesodermal origin such as bone, cartilage, and adipocytes, the company said.